Germany's pharma industry demands legal certainty via location clause

German research-based pharma industry warns that political unpredictability, not calculable risks, threatens investment. A proposed location clause in legislation is seen as a first step toward restoring reliability, but its scope and enforceability remain uncertain. This matters as Germany competes for pharma investment amid global supply-chain diversification.